Immune cell signaling in lupus

Current Opinion in Rheumatology

Volumn 12, Issue 5, 2000, Pages 355-363

  Tsokos, George C ^a,b   Wong, Henry K ^a   Enyedy, Edith J ^a   Nambiar, Madhusoodana P ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; LYMPHOCYTE ANTIGEN RECEPTOR; SYNAPTOTAGMIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR;

B LYMPHOCYTE; GENE OVEREXPRESSION; GENE STRUCTURE; GENETIC TRANSCRIPTION; IMMUNOCOMPETENT CELL; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; CELL CYCLE; CYCLIN-DEPENDENT KINASES; ESTROGENS; GENES, MHC CLASS II; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; NF-KAPPA B; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTION FACTOR AP-1;

EID: 0033849609     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200009000-00001     Document Type: Review

References (60)

1. Overview of cellular immune function in systemic lupus erythematosus
2. The T cell enigma in lupus
3. Immune cell signaling defects in lupus: Activation, anergy and death
4. TCR/CD3 complex-mediated signal transduction pathway in T cells and cell lines from patients with systemic lupus erythematosus
5. Abnormal early TCR/CD3-mediated signaling events of a snRNP- autoreactive lupus T cell clone
6. Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus: Deficient expression of the T-cell receptor zeta chain
7. B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events
8. TCR zeta chain lacking exon 7 in two patients with systemic lupus erythematosus
9. Diminished levels of T cell receptor zeta chains in peripheral blood T lymphocytes from patients with systemic lupus erythematosus
10. A shift from negative to positive selection of autoreactive T cells by the reduced level of TCR signal in TCR-transgenic CD3 zeta-deficient mice
11. Activation-induced proteolysis of cytoplasmic domain of zeta in T cell receptors and Fc receptors
12. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice
13. HIV infection-induced posttranslational modification of T cell signaling molecules associated with disease progression
14. Decreased expression of zeta molecules by T lymphocytes is correlated with disease progression in human immunodeficiency virus-infected persons
15. Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritis
16. T cell receptor complexes containing Fc epsilon RI gamma homodimers in lieu of CD3 zeta and CD3 eta components: A novel isoform expressed on large granular lymphocytes
17. TCR zeta chain in T cell development and selection
18. Qualitatively distinct signaling through T cell antigen receptor subunits
19. Natural killer cells in patients with systemic lupus erythematosus
20. Qualitative and quantitative contributions of the T cell receptor zeta chain to mature T cell apoptosis
21. Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: Role of decreased intracellular TNF-alpha
22. Molecular cloning and chromosomal localization of the human T-cell receptor zeta chain distinction from the molecular CD3 complex
23. Human T-cell receptor zeta chain gene Map position 1 q23.1
24. Functional characterization of a signal transducing motif present in the T cell antigen receptor zeta chain
25. Towards unraveling the complexity of T cell signal transduction
26. Signaling events in T lymphocytes leading to cellular activation or programmed cell death
27. Role of the multiple T cell receptor (TCR)-zeta chain signaling motifs in selection of the T cell repertoire
28. Characterization of in vivo mutated T cell clones from patients with systemic lupus erythematosus
29. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production
30. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes
31. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus
32. Functional dissection of systemic lupus erythematosus using congenic mouse strains
33. Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity
34. Genetic dissection of SLE pathogenesis. Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes
35. Susceptibility to lupus nephritis in the NZB/W model system
36. CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation
37. FcgammaRIIA alleles are heritable risk factors for lupus nephritis
38. Polygenic autoimmune traits: Lyn, CD22, and SHP·1 are limiting elements of a biochemical pathway regularing BCR signaling and selection
39. Enhanced and sustained activation of human B cells by anti-immunoglobulin conjugated to the EBV glycoprotein gp350
40. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation: Relationship between immune complex levels, state of C3 and numbers of receptors for C3b
41. EBV induces normal B cell responses but defective suppressor T cell responses in patients with SLE
42. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus
43. Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent
44. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity
45. Abnormar NF-kappaB activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-relA protein expression
46. G1 arrest and high expression of cyclin kinase and apoptosis inhibitors in accumulated activated/memory phenotype CD4+ cells of older lupus mice
47. The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development
48. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families
49. Estrogen up-regulates bcl-2 and blocks tolerance induction of naive B cells
50. Estrogen response elements can mediate agonist activity of anti-estrogens in human endometrial Ishikawa cells
51. Gender differences in autoimmune diseases: Estrogen increases calcineurin expression in systemic lupus erythematosus
52. Emerging concepts of the molecular basis for estrogen effects on T lymphocytes in systemic lupus erythematosus
53. Inhibition of experimental autoimmune encephalomyelitis by a tyrosine kinase inhibitor
54. Tyrphostin B42 inhibits IL-12-induced tyrosine phosphorylation and activation of Janus kinase-2 and prevents experimental allergic encephalomyelitis
55. Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity
56. B cell development: Signal transduction by antigen receptors and their surrogates
57. Transcriptional regulation of the T cell antigen receptor zeta subunit: Identification of a tissue-restricted promoter
58. The pseudo-immunoreceptor tyrosine-based activation motif of CD5 mediates its inhibitory action on B cell receptor signaling
59. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL- 2 promoter CD28 response element/AP-1 sequence in human T cells
60. In vivo anergized CD4+ T cells express perturbed AP-1 and NF-kappa B transcription factors